Tobacco use prevalence (ages 15+, age-standardized, %) vs Adult obesity prevalence (age-standardized, %) in Andorra

In 2024, tobacco use prevalence (ages 15+, age-standardized, %) in Andorra stood at 35.5%, against 17.1% for adult obesity prevalence (age-standardized, %).

Change the pair

Compare different indicators

The series

Over time

Andorra, spaced by time. Both series are in %, so they share one axis; the legend names each line.

Tobacco use prevalence (ages 15+, age-standardized, %) and Adult obesity prevalence (age-standardized, %)

Unit: % · 44 observations

2 series · one axis

Estimates are listed as such in the table below No figure published for these periods

Tobacco use prevalence (ages 15+, age-standardized, %) and Adult obesity prevalence (age-standardized, %): AndorraTobacco use prevalence (ages 15+, age-standardized, %) and Adult obesity prevalence (age-standardized, %). 2 indicators on one axis: Tobacco use prevalence (ages 15+, age-standardized, %), Adult obesity prevalence (age-standardized, %). 44 observations from 1990 to 2024, ranging from 10.9% to 36%. Latest values: Tobacco use prevalence (ages 15+, age-standardized, %) 35.5% (2024); Adult obesity prevalence (age-standardized, %) 17.1% (2024). % 0 10 20 30 40 1990 1996 2002 2008 2014 2020 36% 17% Tobacco use prevalence (ages 15+, age-standardized, %) Adult obesity prevalence (age-standardized, %)
Tobacco use prevalence (ages 15+, age-standardized, %) and Adult obesity prevalence (age-standardized, %): AndorraTobacco use prevalence (ages 15+, age-standardized, %) and Adult obesity prevalence (age-standardized, %). 2 indicators on one axis: Tobacco use prevalence (ages 15+, age-standardized, %), Adult obesity prevalence (age-standardized, %). 44 observations from 1990 to 2024, ranging from 10.9% to 36%. Latest values: Tobacco use prevalence (ages 15+, age-standardized, %) 35.5% (2024); Adult obesity prevalence (age-standardized, %) 17.1% (2024). % 0 10 20 30 40 1990 1996 2002 2008 2014 2020 36% 17% Tobacco use prevalence (ages 15+, age-standardized, %) Adult obesity prevalence (age-standardized, %)
Tobacco use prevalence (ages 15+, age-standardized, %) and Adult obesity prevalence (age-standardized, %): AndorraTobacco use prevalence (ages 15+, age-standardized, %) and Adult obesity prevalence (age-standardized, %). 2 indicators on one axis: Tobacco use prevalence (ages 15+, age-standardized, %), Adult obesity prevalence (age-standardized, %). 44 observations from 1990 to 2024, ranging from 10.9% to 36%. Latest values: Tobacco use prevalence (ages 15+, age-standardized, %) 35.5% (2024); Adult obesity prevalence (age-standardized, %) 17.1% (2024). % 0 10 20 30 40 1990 1996 2002 2008 2014 2020 36% 17% Tobacco use prevalence (ages 15+, age-standardized, %) Adult obesity prevalence (age-standardized, %)
View the underlying data
Tobacco use prevalence (ages 15+, age-standardized, %) and Adult obesity prevalence (age-standardized, %): Andorra
Indicator Period Type Value
Tobacco use prevalence (ages 15+, age-standardized, %) 2024 Estimate 35.5%
Tobacco use prevalence (ages 15+, age-standardized, %) 2023 Estimate 35.5%
Tobacco use prevalence (ages 15+, age-standardized, %) 2022 Estimate 35.4%
Tobacco use prevalence (ages 15+, age-standardized, %) 2020 Estimate 35.3%
Tobacco use prevalence (ages 15+, age-standardized, %) 2015 Estimate 35.4%
Tobacco use prevalence (ages 15+, age-standardized, %) 2010 Estimate 35.4%
Tobacco use prevalence (ages 15+, age-standardized, %) 2007 Estimate 35.7%
Tobacco use prevalence (ages 15+, age-standardized, %) 2005 Estimate 35.5%
Tobacco use prevalence (ages 15+, age-standardized, %) 2000 Estimate 36%
Adult obesity prevalence (age-standardized, %) 2024 Estimate 17.1%
Adult obesity prevalence (age-standardized, %) 2023 Estimate 17.1%
Adult obesity prevalence (age-standardized, %) 2022 Estimate 17.1%
Adult obesity prevalence (age-standardized, %) 2021 Estimate 17.1%
Adult obesity prevalence (age-standardized, %) 2020 Estimate 17%
Adult obesity prevalence (age-standardized, %) 2019 Estimate 17%
Adult obesity prevalence (age-standardized, %) 2018 Estimate 17%
Adult obesity prevalence (age-standardized, %) 2017 Estimate 17%
Adult obesity prevalence (age-standardized, %) 2016 Estimate 17%
Adult obesity prevalence (age-standardized, %) 2015 Estimate 17%
Adult obesity prevalence (age-standardized, %) 2014 Estimate 16.9%
Adult obesity prevalence (age-standardized, %) 2013 Estimate 16.9%
Adult obesity prevalence (age-standardized, %) 2012 Estimate 16.8%
Adult obesity prevalence (age-standardized, %) 2011 Estimate 16.7%
Adult obesity prevalence (age-standardized, %) 2010 Estimate 16.6%
Adult obesity prevalence (age-standardized, %) 2009 Estimate 16.4%
Adult obesity prevalence (age-standardized, %) 2008 Estimate 16.2%
Adult obesity prevalence (age-standardized, %) 2007 Estimate 15.9%
Adult obesity prevalence (age-standardized, %) 2006 Estimate 15.6%
Adult obesity prevalence (age-standardized, %) 2005 Estimate 15.3%
Adult obesity prevalence (age-standardized, %) 2004 Estimate 14.9%
Adult obesity prevalence (age-standardized, %) 2003 Estimate 14.6%
Adult obesity prevalence (age-standardized, %) 2002 Estimate 14.2%
Adult obesity prevalence (age-standardized, %) 2001 Estimate 13.9%
Adult obesity prevalence (age-standardized, %) 2000 Estimate 13.5%
Adult obesity prevalence (age-standardized, %) 1999 Estimate 13.2%
Adult obesity prevalence (age-standardized, %) 1998 Estimate 12.8%
Adult obesity prevalence (age-standardized, %) 1997 Estimate 12.5%
Adult obesity prevalence (age-standardized, %) 1996 Estimate 12.2%
Adult obesity prevalence (age-standardized, %) 1995 Estimate 11.9%
Adult obesity prevalence (age-standardized, %) 1994 Estimate 11.7%
Adult obesity prevalence (age-standardized, %) 1993 Estimate 11.4%
Adult obesity prevalence (age-standardized, %) 1992 Estimate 11.2%
Adult obesity prevalence (age-standardized, %) 1991 Estimate 11.1%
Adult obesity prevalence (age-standardized, %) 1990 Estimate 10.9%

Shared periods

Side by side

9 periods are published for both series in Andorra as annual figures on the same basis. Comparing anything else would mean comparing different periods.

Period Tobacco use prevalence (ages 15+, age-standardized, %) Adult obesity prevalence (age-standardized, %)
2000 36% WHO 13.5% WHO
2005 35.5% WHO 15.3% WHO
2007 35.7% WHO 15.9% WHO
2010 35.4% WHO 16.6% WHO
2015 35.4% WHO 17% WHO
2020 35.3% WHO 17% WHO
2022 35.4% WHO 17.1% WHO
2023 35.5% WHO 17.1% WHO
2024 35.5% WHO 17.1% WHO

Provenance

Where these numbers come from

Tobacco use prevalence (ages 15+, age-standardized, %)

Age-standardized estimate of current tobacco use prevalence among persons aged 15 years and older, as published by the WHO (tobacco smoking estimates substituted where full tobacco use data is unavailable).

9 observations charted in Andorra · source organisations: WHO

Adult obesity prevalence (age-standardized, %)

Percentage of adults aged 18 and older with a body mass index (BMI) of 30 kg/m² or higher, age-standardized estimate.

35 observations charted in Andorra · source organisations: WHO

Data published under CC BY 4.0. Series A as JSON · Series B as JSON

Keep exploring

Related